Evidence map›Paper›PMID 38396017›Full record

ArticleHarm reduction journal2024

Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma.

Carolina Scaramutti, Belén Hervera, Yanexy Rivera, Teresa A Chueng, David W Forrest, Edward Suarez, David P Serota, Hatoun Alkamli, Katrina Ciraldo, Tyler S Bartholomew and 1 more

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Carolina ScaramuttiDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. cscaramutti@med.miami.edu.
Belén HerveraDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Yanexy RiveraDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Teresa A Chueng2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
David W ForrestDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Edward SuarezDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
David P Serota2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Hatoun AlkamliDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Katrina CiraldoDepartment of Family and Community Medicine & Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Tyler S BartholomewDivision of Health Services Research and Policy, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Hansel E Tookes2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
University of Miami · US

Funding

The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials NetworkUG1DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel J Feaster, Viviana Elizabeth Horigian · 2015 to 2026
$50.6M
Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
In pursuit of a one-stop shop: a hybrid type 1 effectiveness-implementation trial of comprehensive tele-health concierge for people who inject drugsR01DA058352 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Joshua Adam Barocas, Tyler Scott Bartholomew · 2023 to 2026
$2.7M
Tele-Harm Reduction for Rapid Initiation of Antiretrovirals in People who Inject Drugs: a Randomized Controlled TrialDP2DA053720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI TOOKES, HANSEL EMORY · 2021 to 2024
$2.6M
NIDA NIH HHS DP2 DA053720NIDA NIH HHS DP2DA053720NIDA NIH HHS R01 DA058352NIDA NIH HHS T32 DA037801NIDA NIH HHS UG1 DA013720
6 · The paper itself

Abstract

backgroundTele-harm reduction (THR) is a telehealth-enhanced, peer-led, harm reduction intervention delivered within a trusted syringe services program (SSP) venue. The primary goal of THR is to facilitate linkage to care and rapid, enduring virologic suppression among people who inject drugs (PWID) with HIV. An SSP in Miami, Florida, developed THR to circumvent pervasive stigma within the traditional healthcare system.

methodsDuring intervention development, we conducted in-depth interviews with PWID with HIV (n = 25) to identify barriers and facilitators to care via THR. We employed a general inductive approach to transcripts guided by iterative readings of the raw data to derive the concepts, themes, and interpretations of the THR intervention.

resultsOf the 25 PWID interviewed, 15 were in HIV care and adherent to medication; 4 were in HIV care but non-adherent; and 6 were not in care. Themes that emerged from the qualitative analysis included the trust and confidence PWID have with SSP clinicians as opposed to professionals within the traditional healthcare system. Several barriers to treatment were reported among PWID, including perceived and actual discrimination by friends and family, negative internalized behaviors, denial of HIV status, and fear of engaging in care. Facilitators to HIV care included empathy and respect by SSP staff, flexibility of telehealth location, and an overall destigmatizing approach.

conclusionPWID identified barriers and facilitators to receipt of HIV care through the THR intervention. Interviews helped inform THR intervention development, centered on PWID in the destigmatizing environment of an SSP.

Indexed as

Drug UsersHIV InfectionsSubstance Abuse, IntravenousHarm ReductionHealth Services AccessibilityHumansPerceived DiscriminationHarm reductionHIVPWIDStigmaSyringe services programTele-harm reduction

Identifiers

PMID38396017
PMCPMC10893685
OpenAlexW4392100584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.